RxDoctor Payments Data
★ My doctorsLook up a doctor →

Robert Eastlack, MD

Orthopaedic Surgery · la Jolla, CANPI 1861471369

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $2,571,377 of the $3,884,522 with a category attached, or 66.2%. 40 manufacturers reported payments, led by Globus Medical at 45.0% of the total. 2025 is the largest year on record at $1,223,337, 4.9 times the $247,171 reported in 2019. Among orthopaedic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,884,522in general payments, 2019–2025

Across 1,130 payments — averaging $3437.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$1.7M
  • Si-bone, Inc.$1.1M
  • Orthofix Medical, Inc.$426K
  • Aesculap Implant Systems, LLC$151K
  • Seaspine Orthopedics Corporation$145K
  • Medtronic$84K
  • plus $238K from 34 others
$109,772in research payments, 2019–2025

Across 12 payments — averaging $9147.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$50K
  • Spinal Elements, Inc.$44K
  • Si-bone, Inc.$16K
$100,000in ownership & investment interests, 2019–2025

Across 4 payments — averaging $25,000 each. An ownership or investment interest held by the physician or an immediate family member.

  • Osteocentric Technologies, Inc.$100K
  • Globus Medical$0

What the payments were for

  • Royalty or licence$2,571,37766%
  • Consulting fees$1,072,20628%
  • Speaking & faculty fees$159,0024%
  • Travel & lodging$53,6401%
  • Food & beverage$27,7271%
  • Education$1180%
  • Gifts$780%
  • Entertainment$3730%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Globus Medical(2 entities)173$1,747,075
Si-bone, Inc.393$1,094,083
Orthofix Medical, Inc.75$425,774
Aesculap Implant Systems, LLC14$150,598
Seaspine Orthopedics Corporation95$144,602
Medtronic(2 entities)123$84,114
Stryker44$49,096
Neo Spine USA, Inc.24$41,383
Kuros Biosciences USA, Inc36$35,102
Spinal Elements, Inc.6$18,611
Osteocentric Technologies, Inc.14$11,464
Silony Medical Corp.9$10,807
Intrinsic Therapeutics25$10,720
Curiteva, Inc.3$9,453
MML US, Inc.15$7,442
Radius Health, Inc.12$7,163
Medical Device Business Services, Inc.7$7,047
Alphatec Spine, Inc12$6,811
Synthes GmbH12$5,826
Smaio SA1$3,466
Premia Spine, Ltd.1$3,200
Biedermann Motech, Inc.3$2,704
Amgen4$2,425
Lilly USA, LLC1$1,900
Smaio USA Corporation4$1,435
Pacira Pharmaceuticals Incorporated1$663
Bioventus LLC4$283
Smith+Nephew1$249
Davol Inc.5$239
Surgalign Spine Technologies, Inc.2$193
Integrity Implants Inc.1$168
Highridge Medical LLC1$102
Relievant Medsystems, Inc.1$89
Carbofix Spine Inc1$78
Theradaptive, Inc.2$78
Sanofi-aventis U.S. LLC1$21
AbbVie1$18
Baxter Healthcare1$17
Nevro Corp.1$13
Xtant Medical Inc1$6

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,884,522 in reported general payments places this provider in the 95th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California →

Medicare billing

Part B allowed, 2024
$1,117,457
Medicare patients
730
Services billed
7,316

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin83$986
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen77$794
Oxycodone Hcl54$489
Cyclobenzaprine Hcl52$459
Celecoxib32$387
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen29$366
Methylprednisolone69$316
Mupirocin37$246
Tizanidine Hcl25$84
Hydromorphone Hcl12$62
Tramadol Hcl16$54
Diazepam13$50
Alprazolam15$10

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in la Jolla

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →